These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16886139)

  • 21. Medicare's Reimbursement Reduction for Nerve Conduction Studies: Effect on Use and Payments.
    Callaghan BC; Burke JF; Skolarus LE; Jacobson RD; De Lott LB; Kerber KA
    JAMA Intern Med; 2016 May; 176(5):697-9. PubMed ID: 27018752
    [No Abstract]   [Full Text] [Related]  

  • 22. Countries should encourage use of generic substitutes, says OECD.
    Zarocostas J
    BMJ; 2008 Oct; 337():a1996. PubMed ID: 18842656
    [No Abstract]   [Full Text] [Related]  

  • 23. How Episode-Based Payment Affects Health Care Spending.
    Natl Bur Econ Res Bull Aging Health; 2018; (1):1-2. PubMed ID: 29688657
    [No Abstract]   [Full Text] [Related]  

  • 24. [Health economics evaluations are of great significance for Pharmaceutical Benefit Board's decisions].
    Persson U; Ramsberg J
    Lakartidningen; 2007 Oct 17-23; 104(42):3046-50. PubMed ID: 17985712
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study.
    Noize P; Bazin F; Dufouil C; Lechevallier-Michel N; Ancelin ML; Dartigues JF; Tzourio C; Moore N; Fourrier-Réglat A
    Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):310-9. PubMed ID: 19241438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals.
    Andersson K; Bergström G; Petzold MG; Carlsten A
    Health Policy; 2007 May; 81(2-3):376-84. PubMed ID: 16945449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical and dental care utilization and expenditures under Medicaid and private health insurance.
    Ku L
    Med Care Res Rev; 2009 Aug; 66(4):456-71. PubMed ID: 19389727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does generic substitution always make sense?
    Greenberg PE
    J Med Econ; 2008; 11(3):547-53. PubMed ID: 19450104
    [No Abstract]   [Full Text] [Related]  

  • 29. [2012 health national accounts: an apparent stability?].
    Franc C
    Med Sci (Paris); 2014 Feb; 30(2):199-203. PubMed ID: 24572120
    [No Abstract]   [Full Text] [Related]  

  • 30. PBMs' rebate income threatened by lawsuits and move to generics.
    Sipkoff M
    Manag Care; 2008 Mar; 17(3):11-2. PubMed ID: 18447152
    [No Abstract]   [Full Text] [Related]  

  • 31. Generic substitution. Reimbursement requires reform.
    Duerden MG
    BMJ; 2010 Jul; 341():c3566. PubMed ID: 20610497
    [No Abstract]   [Full Text] [Related]  

  • 32. Relationship between generic and preferred-brand prescription copayment differentials and generic fill rate.
    Mager DE; Cox ER
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):347-52. PubMed ID: 17567235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. European MPs back moves for generic drugs to be made available more quickly.
    Watson R
    BMJ; 2013 Feb; 346():f906. PubMed ID: 23403832
    [No Abstract]   [Full Text] [Related]  

  • 34. Reimbursement for drugs -- a register study comparing economic outcome for five healthcare centres in areas with different socioeconomic conditions.
    Semark B; Fredlund K; Astrand B; Brudin L
    Scand J Public Health; 2009 Aug; 37(6):647-53. PubMed ID: 19546143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overview of the Medicare and Medicaid programs.
    Hoffman ED; Klees BS; Curtis CA
    Health Care Financ Rev Stat Suppl; 2004; ():1-380. PubMed ID: 17366751
    [No Abstract]   [Full Text] [Related]  

  • 36. Overview of the medicare and medicaid programs.
    Hoffman ED; Klees BS; Curtis CA
    Health Care Financ Rev Stat Suppl; 2005; ():1-281, 283-304. PubMed ID: 17373028
    [No Abstract]   [Full Text] [Related]  

  • 37. The impact of nonreferral outpatient co-payment on medical care utilization and expenditures in Taiwan.
    Chen LC; Schafheutle EI; Noyce PR
    Res Social Adm Pharm; 2009 Sep; 5(3):211-24. PubMed ID: 19733822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Out-of-pocket costs to users: medicine options for hypertension.
    Arredondo A
    Am J Hypertens; 2008 May; 21(5):492. PubMed ID: 18437138
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries.
    Saleh SS; Weller W; Hannan E
    J Health Hum Serv Adm; 2007; 30(1):50-74. PubMed ID: 17557696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generic boost. Bill, acquisitions could help hospitals save money.
    Rhea S
    Mod Healthc; 2009 Apr; 39(16):17. PubMed ID: 19419134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.